Altis Biosystems
Medical AI · Drug Discovery
$5.2Mtotal raised · 15 rounds on record
$2.1Mlatest round · Venture round · Mar 2025 · 19 mo ago
$11.3Mgrants · 13 grants · CORDIS
10+team · employees, estimated range
Overview
Altis builds RepliGut human intestinal models from stem cells, so pharma can predict drug absorption, metabolism, and GI toxicity in people, not animals.
Funding and backers
Total raised
$5.2M
15 rounds on record
Latest round
$2.1M
Venture round · Mar 2025 · 19 mo ago
Team
11-50
employees, estimated range
Grants
$11.3M
13 grants · CORDIS
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 15, 2025
Won a grant $836k · CORDIS
Sep 1, 2023
Won a grant $343k · CORDIS
Jul 1, 2023
Won a grant $1.8M · CORDIS
Sep 30, 2022
Won a grant $1.9M · CORDIS
Jul 1, 2022
Won a grant $257k · CORDIS
May 9, 2022
Won a grant $294k · CORDIS
May 1, 2022
Won a grant $2M · CORDIS
Jul 1, 2021
Won a grant $257k · CORDIS
Sep 1, 2020
Won a grant $1.4M · CORDIS
Jul 22, 2020
Board appointment Joseph McMahon, Director · SEC Form D
Apr 1, 2020
Won a grant $246k · CORDIS
Jan 17, 2020
New executive Michael Biron, Executive Officer, Director · SEC Form D
Dec 30, 2019
Raised a round Venture round $3.1M · SEC Form D
Sep 13, 2019
Won a grant $1.5M · CORDIS
Aug 1, 2019
Won a grant $223k · CORDIS
Sep 21, 2018
Won a grant $225k · CORDIS
2018
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Jun 2025 | $836k | — | CORDIS |
| Venture round | Mar 2025 | $2.1M | — | SEC Form D |
| Grant | Sep 2023 | $343k | — | CORDIS |
| Grant | Jul 2023 | $1.8M | — | CORDIS |
| Grant | Sep 2022 | $1.9M | — | CORDIS |
| Grant | Jul 2022 | $257k | — | CORDIS |
| Grant | May 2022 | $294k | — | CORDIS |
| Grant | May 2022 | $2M | — | CORDIS |
| Grant | Jul 2021 | $257k | — | CORDIS |
| Grant | Sep 2020 | $1.4M | — | CORDIS |
| Grant | Apr 2020 | $246k | — | CORDIS |
| Venture round | Dec 2019 | $3.1M | — | SEC Form D |
| Grant | Sep 2019 | $1.5M | — | CORDIS |
| Grant | Aug 2019 | $223k | — | CORDIS |
| Grant | Sep 2018 | $225k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Altis Biosystems, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Christopher SimsExecutive OfficerSEC Form D
Benjamin ScruggsExecutive Officer, DirectorSEC Form D
Jimmy SmedleyExecutive OfficerSEC Form D
Michael BironExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Deep Origin, Toxometris
backs Stemnovate
Similar startupsby what they do, their industry and backers
AI-powered in silico toxicology platform for drug discovery. Predict mutagenicity, hERG, DILI, ADME and 55+ models from SMILES…
Build next-generation cell engineering and drug discovery workflows with Portal mechanoporation for broad intracellular delivery across…
AnaBios provides high quality human tissue and cells, including heart, lung and dorsal root ganglia, for drug discovery & academic research.
Asset scouting, competitive intelligence, due diligence, and launch research for pharma teams and investors. AI-assisted analysis reviewed…
Stemnovate page on drug discovery. The platforms provide solutions for next gen liver, heart and brain cell modelling.
FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.
Financials
Total raised
$16.5M
Latest round
Grant
Funding rounds
15
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2025 | $836k | Details |
| Venture - Series Unknown | 2025 | $2.1M | Details |
| Grant | 2023 | $343k | Details |
| Grant | 2023 | $1.8M | Details |
| Grant | 2022 | $1.9M | Details |
| Grant | 2022 | $257k | Details |
| Grant | 2022 | $294k | Details |
| Grant | 2022 | $2M | Details |
| Grant | 2021 | $257k | Details |
| Grant | 2020 | $1.4M | Details |
| Grant | 2020 | $246k | Details |
| Venture - Series Unknown | 2019 | $3.1M | Details |
| Grant | 2019 | $1.5M | Details |
| Grant | 2019 | $223k | Details |
| Grant | 2018 | $225k | Details |
People
Christopher Sims
Executive Officer
Benjamin Scruggs
Executive Officer, Director
Jimmy Smedley
Executive Officer
Michael Biron
Executive Officer, Director
Christopher Perkins
Director
Michael Dial
Director
Susan Mahony
Director
Kevin Causey
Director
Samuel Franklin
Director
Joseph McMahon
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham
United States
HQ
4.9 out of 5 stars from 47 reviews
10-50 est. staff